Literature DB >> 4821219

Investigational drugs for the treatment of malignant melanoma.

K Hellmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4821219      PMCID： PMC1645249     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  3 in total

1.  Some pharmacokinetic aspects of 5-(dimethylriazeno)-imidazole-4-carboxamide in the dog.

Authors:  T L Loo; B B Tanner; G E Housholder; B J Shepard
Journal:  J Pharm Sci       Date:  1968-12       Impact factor: 3.534

2.  Incidence and significance of melanogenuria.

Authors:  J C Crawhall; B J Hayward; C A Lewis
Journal:  Br Med J       Date:  1966-06-11

Review 3.  5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.

Authors:  S K Carter; M A Friedman
Journal:  Eur J Cancer       Date:  1972-02       Impact factor: 9.162
  3 in total
  1 in total

1.  [Correction of rheumatic forefoot. The value of a combined arthrodesis of the first toe and resection of metatarsal heads 2-5].

Authors:  S Heitkemper; A Pingsman; A Quitmann; T Patsalis
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.